{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Scribe Therapeutics", "item": "https://www.patentleaderboard.com/2021/company/scribe-therapeutics"}, {"@type": "ListItem", "position": 4, "name": "Benjamin OAKES", "item": "https://www.patentleaderboard.com/2021/inventor/fl:be_ln:oakes-1"}]}

Home › 2021 › Scribe Therapeutics › Benjamin OAKES

Benjamin OAKES — 2 Patents in 2021

University of California: 2 patents #105 of 1,821Top 6%

El Cerrito, CA: #11 of 36 inventorsTop 35%

California: #13,721 of 66,859 inventorsTop 25%

Overall (2021): #177,797 of 548,734Top 35%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date
11180778	Variant RNA-guided polypeptides and methods of use	David Savage, Jennifer A. Doudna, Rayka Yokoo	2021-11-23
11008555	Variant Cas9 polypeptides comprising internal insertions	David Savage, Dana Nadler, Abraham I. Flamholz, Jennifer A. Doudna	2021-05-18

Benjamin OAKES — 2 Patents in 2021

Issued Patents 2021

Patent Widget